Assessment of Cardiovascular Disease Among Predominantly Black Gout Patients

被引:0
|
作者
Chandrakumar, Harshith Priyan [1 ]
Puskoor, Anoop Venkat [1 ]
Chillumuntala, Seeta [1 ]
Sharif, Sara [1 ]
Mora, Diego Cepeda [1 ]
Gupta, Tanuj [1 ]
Tadayoni, Ashkan [1 ]
Zonnoor, Seyedeh Leila [1 ]
Celiker, Pelin [2 ]
Yakoubovitch, Stephanie [2 ]
Tsai, Andrew [2 ]
Chiu, Courtney [2 ]
Kazi, Anan [2 ]
Freilich, Michael [2 ]
Saleh, Ahmad [2 ]
Moon, Seung Jae [2 ]
Cruickshank, Kingsley [2 ]
Li, Shuojohn [2 ]
Katz, Julie [2 ]
Eichler, Joanna [2 ]
Salciccioli, Louis [3 ]
McFarlane, Isabel M. [1 ,4 ]
机构
[1] SUNY Downstate Hlth Sci Univ, Dept Internal Med, Brooklyn, NY 11203 USA
[2] SUNY Downstate Hlth Sci Univ, Coll Med, Brooklyn, NY USA
[3] SUNY Downstate Hlth Sci Univ, Dept Cardiol, Brooklyn, NY USA
[4] SUNY Downstate Hlth Sci Univ, Dept Med, 450 Clarkson Ave, POB 50, Brooklyn, NY 11203 USA
关键词
gout; cardiovascular disease; heart failure; mortality; uric acid; SERUM URIC-ACID; RHEUMATOID-ARTHRITIS; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DIAGNOSTIC RULE; HEART-FAILURE; PRIMARY-CARE; RISK; ECHOCARDIOGRAPHY; RECOMMENDATIONS;
D O I
10.1097/RHU.0000000000001948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Although the association between gout and cardiovascular disease (CVD) has been extensively studied, scarce data are available for the Black population. We aimed to assess the association between gout and CVD in a predominantly Black urban population with gout. Methods: A cross-sectional analysis was performed between a gout cohort and an age-/sex-matched control group. Clinical parameters and 2D echocardiograms were reviewed for the patients with gout and heart failure (HF). The primary outcome studied includes the prevalence and strength of association between gout and CVD. Secondary outcomes studied includes strength of association of gout and HF categorized by ejection fraction, mortality, and HF readmissions. Results: Four hundred seventy-one patients with gout had a mean age of 63.7 +/- 0.5 years; 89% were Black, 63% were men, and mean body mass index was 31.3 +/- 0.4 kg/m(2). Hypertension, diabetes mellitus, and dyslipidemia were present in 89%, 46%, and 52%, respectively. Compared with controls, patients with gout had significantly higher rates of angina, arrhythmia, coronary artery disease/stents, myocardial infarction, coronary artery bypass graft surgery, cerebrovascular accident, and peripheral vascular disease. The adjusted odds ratio for CVD was 2.9 (95% confidence interval, 1.9-4.5; p < 0.001). Gout patients had a higher prevalence of HF with 45% (n = 212) compared with controls with 9.4% (n = 44). Adjusted odds ratio for HF risk was 7.1 (95% confidence interval, 4.7-10.6; p < 0.01). Conclusions: Gout in a predominantly Black population confers 3 times the CVD risk and 7 times HF-specific risk compared with age- and sex-matched cohort. Further research is needed to confirm our findings and to develop interventions to reduce morbidity associated with gout.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 50 条
  • [21] CRP, but not ESR, associated with disease severity and cardiovascular risk in patients with gout
    Ilinykh, E. V.
    Barskova, V. G.
    Alexandrova, E. N.
    Novikov, A. A.
    Nassonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 433 - 434
  • [22] Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting
    Sancar, M.
    Akyildiz, E.
    Okuyan, B.
    Rabus, S. Apikoglu
    Carli, B. Soydeger
    Yilmaz, Z.
    Izzettin, F. V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 429 - 430
  • [23] Gout and cardiovascular disease: crystallized confusion
    Abeles, Aryeh M.
    Pillinger, Michael H.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (02) : 118 - 124
  • [24] Hyperuricemia, Gout, and Cardiovascular Disease: An Update
    Abeles, Aryeh M.
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (03)
  • [25] UPDATE ON COMPARATIVE CARDIOVASCULAR SAFETY OF FEBUXOSTAT VERSUS ALLOPURINOL AMONG PATIENTS WITH GOUT
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 385 - 385
  • [26] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    INTERNIST, 2020, 61 (05): : 530 - 532
  • [27] Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout
    Kyung-Ann Lee
    Se-Ri Ryu
    Seong-Jun Park
    Hae-Rim Kim
    Sang-Heon Lee
    Clinical Rheumatology, 2018, 37 : 1351 - 1358
  • [28] Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout
    Lee, Kyung-Ann
    Ryu, Se-Ri
    Park, Seong-Jun
    Kim, Hae-Rim
    Lee, Sang-Heon
    CLINICAL RHEUMATOLOGY, 2018, 37 (05) : 1351 - 1358
  • [29] Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment
    Andres, Mariano
    Antonio Bernal, Jose
    Sivera, Francisca
    Quilis, Neus
    Carmona, Loreto
    Vela, Paloma
    Pascual, Eliseo
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1263 - 1268
  • [30] The Effects of Liver Disease on Cardiovascular Mortality Among Patients With Cardiovascular Disease
    Atem, Ngum Kikah
    Weerakoon, Sitara M.
    Olanipekun, Titilope
    Abe, Temidayo
    Atem, Folefac
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1602 - S1602